Sharp Therapeutics Corp.
SHRXF
$1.58
-$0.08-4.81%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.17M | -3.33M | -2.92M | -5.29M | -3.26M |
| Total Depreciation and Amortization | 98.30K | 120.50K | 99.70K | 85.00K | 100.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 945.60K | -1.70M | -1.76M | 849.10K | -515.10K |
| Change in Net Operating Assets | 298.60K | -415.40K | -493.10K | -56.50K | 60.10K |
| Cash from Operations | -4.83M | -5.32M | -5.07M | -4.41M | -3.62M |
| Capital Expenditure | -- | 0.00 | 0.00 | 16.60K | -14.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 5.10K | 5.10K | 5.10K | 5.10K |
| Cash from Investing | -- | 5.10K | 5.10K | 21.70K | -9.40K |
| Total Debt Issued | -- | 0.00 | 950.00K | 2.20M | 2.20M |
| Total Debt Repaid | -200.00K | -436.80K | -436.80K | -436.80K | -436.80K |
| Issuance of Common Stock | 2.52M | 7.45M | 7.45M | 4.96M | 5.46M |
| Repurchase of Common Stock | -- | -- | -500.00K | -500.00K | -500.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 400.00K | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 2.32M | 7.42M | 7.46M | 6.23M | 6.73M |
| Foreign Exchange rate Adjustments | -19.80K | 31.10K | 26.00K | -19.90K | 6.10K |
| Miscellaneous Cash Flow Adjustments | -- | -400.00K | 500.00K | 0.00 | 0.00 |
| Net Change in Cash | -2.53M | 1.73M | 2.92M | 1.82M | 3.11M |